Vir Biotechnology Inc (VIR)
9.39
+0.02
(+0.21%)
USD |
NASDAQ |
Nov 05, 09:56
Vir Biotechnology Max Drawdown (5Y): 91.26% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 91.26% |
| September 30, 2024 | 91.26% |
| August 31, 2024 | 90.82% |
| July 31, 2024 | 90.82% |
| June 30, 2024 | 90.82% |
| May 31, 2024 | 90.82% |
| April 30, 2024 | 90.82% |
| March 31, 2024 | 90.66% |
| February 29, 2024 | 90.66% |
| January 31, 2024 | 90.66% |
| December 31, 2023 | 90.66% |
| November 30, 2023 | 90.66% |
| October 31, 2023 | 90.66% |
| September 30, 2023 | 89.00% |
| August 31, 2023 | 85.22% |
| July 31, 2023 | 84.71% |
| June 30, 2023 | 78.02% |
| May 31, 2023 | 78.02% |
| April 30, 2023 | 78.02% |
| March 31, 2023 | 78.02% |
| February 28, 2023 | 78.02% |
| January 31, 2023 | 78.02% |
| December 31, 2022 | 78.02% |
| November 30, 2022 | 78.02% |
| October 31, 2022 | 78.02% |
| Date | Value |
|---|---|
| September 30, 2022 | 78.02% |
| August 31, 2022 | 77.03% |
| July 31, 2022 | 77.03% |
| June 30, 2022 | 77.03% |
| May 31, 2022 | 77.03% |
| April 30, 2022 | 75.50% |
| March 31, 2022 | 74.49% |
| February 28, 2022 | 69.68% |
| January 31, 2022 | 62.72% |
| December 31, 2021 | 62.72% |
| November 30, 2021 | 62.72% |
| October 31, 2021 | 59.64% |
| September 30, 2021 | 57.99% |
| August 31, 2021 | 57.99% |
| July 31, 2021 | 57.62% |
| June 30, 2021 | 57.62% |
| May 31, 2021 | 57.62% |
| April 30, 2021 | 57.62% |
| March 31, 2021 | 57.62% |
| February 28, 2021 | 57.62% |
| January 31, 2021 | 57.62% |
| December 31, 2020 | 57.62% |
| November 30, 2020 | 57.62% |
| October 31, 2020 | 53.67% |
| September 30, 2020 | 53.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
25.36%
Minimum
Nov 2019
91.26%
Maximum
Sep 2024
69.48%
Average
76.27%
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| Biomarin Pharmaceutical Inc | 52.14% |
| Arbutus Biopharma Corp | 93.95% |
| GlycoMimetics Inc | 97.94% |
| FibroGen Inc | 99.46% |